EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protein Profile of Multiple Myeloma‐Derived Extracellular Vesicles for the Discovery of Novel Myeloma‐Related Biomarkers

Natalia Platonova iD, Gilda Aiello, Domenica Ronchetti, Valentina Citro, Rosanna Asselta, Lavinia Casati, Domenica Giannandrea, Elisa Taiana, Antonino Neri, Gloria Sini, Elisabetta Calzavara, Mauro Turrini und 2 weitere

Cancer Science · 2026

DOI: 10.1111/cas.70473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2026. Verfasst von Natalia Platonova und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Multiple Myeloma, Extracellular Vesicles, Biomarkers, Tumor, Proteome. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Italian Ministry of Research, under the complementary actions to the NRRP "D34Health Digital Driven Diagnostics, prognostics and therapeutics for sustainable h…, Fondazione AIRC per la ricerca sul cancro ETS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite therapeutic advances, multiple myeloma (MM) remains characterized by progression and relapse, underscoring the need for reliable biomarkers for early detection and monitoring. Extracellular vesicles (EV) are cell‐derived, lipid bilayer–enclosed particles that mediate intercellular communication and circulate in body fluids, making them promising biomarkers. This study compares the proteome of MM‐derived EV with parental cells and evaluates whether EV represent a superior source of MM‐specific biomarkers. We used high‐resolution mass spectrometry to analyze MM cell lines and their EV. Cell line–derived EV offer a cleaner, tumor‐specific protein profile, minimizing background from nonmalignant cells and improving biomarker accuracy. MS datasets were subjected to bioinformatic analysis, followed by functional enrichment using gene set libraries such as Gene Ontology, Jensen Compartments, TRRUST and DisGeNET, to extend interpretation beyond limited protein databases. Compared to cellular proteins, the EV proteome was enriched in functions related to oncogenic signaling, transcriptional regulation and MM pathophysiology, strengthening its potential as a cancer‐related biomarker source. DisGeNET identified cancer‐related proteins that were further evaluated to identify MM‐specific candidates analyzing MM patients' gene expression databases containing clinical data. This led to the identification of macrophage migration inhibitory factor (MIF) and prohibitin. ELISA on plasma from MM patients detected significantly increased MIF levels in smoldering and active MM compared with healthy donors. Approximately half of circulating MIF was EV‐associated in MM patients, indicating that MIF is distributed between vesicular and soluble plasma fractions and underscoring its potential as a noninvasive biomarker for MM early detection and patient monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaExtracellular VesiclesBiomarkers, TumorProteomeHumansCell Line, TumorProhibitinsMacrophage Migration-Inhibitory FactorsRepressor ProteinsIntramolecular OxidoreductasesProteomics

Stichwörter der Autor:innen

biomarkersextracellular vesiclesmigration inhibitory factormultiple myelomaproteomics

Substanzen

Biomarkers, TumorProhibitinsMacrophage Migration-Inhibitory FactorsRepressor ProteinsMIF protein, humanIntramolecular OxidoreductasesProteome

Autor:innen und Institutionen

  • Department of Health Sciences, University of Milan, Milan, Italy.
  • Department of Human Science and Quality of Life Promotion, Telematic University San Raffaele, Rome, Italy.
  • Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

ORCID-Profile: Natalia Platonova

Förderung

  • Associazione Italiana per la Ricerca sul Cancro
  • Italian Ministry of Research, under the complementary actions to the NRRP "D34Health Digital Driven Diagnostics, prognostics and therapeutics for sustainable h…
  • Fondazione AIRC per la ricerca sul cancro ETS

Zitieren

APA

Platonova, N., Aiello, G., Ronchetti, D., Citro, V., Asselta, R., Casati, L., Giannandrea, D., Taiana, E., Neri, A., Sini, G., Calzavara, E., Turrini, M., D'Amato, A., & Chiaramonte, R. (2026). Protein Profile of Multiple Myeloma‐Derived Extracellular Vesicles for the Discovery of Novel Myeloma‐Related Biomarkers. Cancer Science. https://doi.org/10.1111/cas.70473

Vancouver

Platonova N, Aiello G, Ronchetti D, Citro V, Asselta R, Casati L, et al. Protein Profile of Multiple Myeloma‐Derived Extracellular Vesicles for the Discovery of Novel Myeloma‐Related Biomarkers. Cancer Science. 2026. doi:10.1111/cas.70473

BibTeX
@article{Platonova2026,
  author = {Platonova, Natalia and Aiello, Gilda and Ronchetti, Domenica and Citro, Valentina and Asselta, Rosanna and Casati, Lavinia and Giannandrea, Domenica and Taiana, Elisa and Neri, Antonino and Sini, Gloria and Calzavara, Elisabetta and Turrini, Mauro and D'Amato, Alfonsina and Chiaramonte, Raffaella},
  title = {Protein Profile of Multiple Myeloma‐Derived Extracellular Vesicles for the Discovery of Novel Myeloma‐Related Biomarkers},
  journal = {Cancer Science},
  year = {2026},
  doi = {10.1111/cas.70473}
}
Kostenlos starten →